Answers are grounded in this paper and cite their sources.
2 challenging because efficient triplet emission generally requires a rigid molecular environment that is difficult to establish in situ. Here, we report a dual-microcapsule strategy that activates ultralong RTP through damage-triggered in situ polymerization. Two complementary types of microcapsules, separately encapsulating an epoxy precursor and an amine solution containing organic phosphors, were incorporated into a coating. Mechanical damage ruptured both microcapsules, allowing the released components to undergo localized polymerization and form a rigid cross-linked epoxy network that suppresses nonradiative deactivation of the phosphors and enables persistent RTP at the damaged region. Among the investigated luminogens, the amino-substituted phosphor exhibited the best performance, delivering an RTP lifetime of 1857 ms together with remarkable resistance to water, organic solvents, and extremely acidic and alkaline environments. The localized RTP activation enabled high-contrast visualization of scratches and compressive damage. Furthermore, the time-dependent organic afterglow was exploited to construct dynamic multilevel anti-counterfeiting patterns with programmable temporal information. This work establishes damage-triggered in situ polymerization as a general strategy for on-demand activation of organic RTP, providing a versatile platform for intelligent damage self-reporting, dynamic anti-counterfeiting, and advanced mechanoresponsive photonic materials.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: